Drug Shortage Report for MYLAN-AMIODARONE
Report ID | 4090 |
Drug Identification Number | 02240604 |
Brand name | MYLAN-AMIODARONE |
Common or Proper name | Amiodarone |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | AMIODARONE HYDROCHLORIDE |
Strength(s) | 200MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100BT |
ATC code | C01BD |
ATC description | ANTIARRHYTHMICS, CLASS I AND III |
Reason for shortage | Shortage of an active ingredient. |
Anticipated start date | 2017-06-04 |
Actual start date | |
Estimated end date | |
Actual end date | 2017-05-01 |
Shortage status | Avoided shortage |
Updated date | 2017-05-04 |
Company comments | Duplicate report. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-03-23 | English | Compare |
v2 | 2017-03-23 | French | Compare |
v3 | 2017-05-04 | English | Compare |
v4 | 2017-05-04 | English | Compare |
v5 | 2017-05-04 | French | Compare |
Showing 1 to 5 of 5